Peter Gray is a Cardiology physician. OpenAlex indexes 11 publications with 352 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3 Irongate Ctr
Glens Falls, NY 128013471
Telephone
518-793-4409Registry record last updated 2 Oct 2014.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Pharmaceuticals, IncProgram year20234 payments
- Novartis Pharmaceuticals CorporationProgram year20232 payments
- Merck Sharp & Dohme LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.4%Beta blocker17.3%Metoprolol Succinate40%Metoprolol Tartrate23%Carvedilol22%Sotalol12%Atenolol3%Part D<11 patientsStatin13.8%Rosuvastatin Calcium71%Atorvastatin Calcium20%Pravastatin Sodium5%Simvastatin4%Part D<11 patients+ 14 more classes in this area
Blood & clotting
13.9%Factor Xa inhibitor8.4%Eliquis55%Xarelto45%Part D≥41 patientsP2Y12 inhibitor3.8%Clopidogrel100%Part D≥32 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.4%Potassium supplement2.1%Potassium Chloride100%Part D≥16 patientsProton pump inhibitor0.8%Omeprazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bronchoalveolar Lavage In Ponies With Heaves During Disease Remission
Veterinary Clinical Pathology
1993 - Effects of xylazine on airway function in ponies with recurrent airway obstruction
American Journal of Veterinary Research
1992 - Decreased Airway Mucosal Prostaglandin E2 Production during Airway Obstruction in an Animal Model of Asthma
American Review of Respiratory Disease
1992 - Epithelial Strips: An Alternative Technique for Examining Arachidonate Metabolism in Equine Tracheal Epithelium
American Journal of Respiratory Cell and Molecular Biology
1992
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”